Shandong Keyuan Pharmaceutical CoSZSE:301281 -1.12%67 Interest Coverage is 614.00 as of Mar. 2026, which is 420% above its 10-year median of 118.08. GuruFocus rates SZSE:301281 with a GF Score™ of 67/100 and a GF Value™ of ¥30.41 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 687 Drug Manufacturers companies, Shandong Keyuan Pharmaceutical Co ranks better than 79.04% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Shandong Keyuan Pharmaceutical Co's
Operating Income
for the
three
months ended in Mar. 2026 was ¥36.2 Mil. Shandong Keyuan Pharmaceutical Co's Interest Expense for the
three
months ended in Mar. 2026 was ¥-0.1 Mil.
Shandong Keyuan Pharmaceutical Co's interest coverage for the quarter that ended in Mar. 2026 was 614.00.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Shandong Keyuan Pharmaceutical Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Shandong Keyuan Pharmaceutical Co's Interest Coverage or its related term are showing as below:
SZSE:301281'
s Interest Coverage Range Over the Past 10 Years
Min: 2.37 Med: 118.08 Max: 2622.53
Current: 102.85
SZSE:301281's Interest Coverage is ranked better than 79.04% of 687
companies
in the Drug Manufacturers industry
Industry Median: 12.75
vs SZSE:301281: 102.85
Shandong Keyuan Pharmaceutical Co (SZSE:301281) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Shandong Keyuan Pharmaceutical Co Interest Coverage Related Terms
Shandong Keyuan Pharmaceutical Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Shandong Keyuan Pharmaceutical Co Interest Coverage Chart
SZSE:301281 vs LLY, JNJ, ABBV: Interest Coverage Comparison
For the Drug Manufacturers - General subindustry, Shandong Keyuan Pharmaceutical Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Keyuan Pharmaceutical Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shandong Keyuan Pharmaceutical Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Shandong Keyuan Pharmaceutical Co's Interest Coverage falls into.
Shandong Keyuan Pharmaceutical Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Keyuan Pharmaceutical Co (SZSE:301281) has a Interest Coverage of 614.00 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Shandong Keyuan Pharmaceutical Co and its competitors. This is 420% above median its historical median of 118.08. Over the past decade, Shandong Keyuan Pharmaceutical Co's Interest Coverage has ranged from 2.37 to 2,622.53. According to the industry distribution chart, Shandong Keyuan Pharmaceutical Co ranks #144 out of 687 companies in the Drug Manufacturers industry, placing it in the top 21%.
Is Shandong Keyuan Pharmaceutical Co's Interest Coverage too high?
Shandong Keyuan Pharmaceutical Co's current Interest Coverage of 614.00 is 420% above median its 10-year median of 118.08. Over the past 10 years, this metric has ranged from a low of 2.37 to a high of 2,622.53. The Drug Manufacturers industry median Interest Coverage is 12.75. Shandong Keyuan Pharmaceutical Co's value of 614.00 is 4715.7% above this industry median. Based on the distribution chart, Shandong Keyuan Pharmaceutical Co ranks #144 out of 687 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Shandong Keyuan Pharmaceutical Co has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Keyuan Pharmaceutical Co's Interest Coverage compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Shandong Keyuan Pharmaceutical Co ranks #144 out of 687 companies for Interest Coverage. This places Shandong Keyuan Pharmaceutical Co in the top 21% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 12.75. Shandong Keyuan Pharmaceutical Co's value of 614.00 is 4715.7% above this benchmark. Historically, Shandong Keyuan Pharmaceutical Co's own Interest Coverage has ranged from 2.37 to 2,622.53 over the past decade. While the company's 10-year median is 118.08 vs. the industry median of 12.75, Shandong Keyuan Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.75, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Keyuan Pharmaceutical Co's current Interest Coverage of 614.00 is 4715.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Shandong Keyuan Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Keyuan Pharmaceutical Co's current Interest Coverage is 614.00, which is 420% above median its own 10-year median of 118.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Keyuan Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Keyuan Pharmaceutical Co (SZSE:301281) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥30.41, compared to a current price of ¥50.42 — trading 65.8% above its estimated fair value. The current Interest Coverage is 614.00, which is 420% above median its 10-year median of 118.08 and 4715.7% above the Drug Manufacturers industry median of 12.75. Shandong Keyuan Pharmaceutical Co's overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Shandong Keyuan Pharmaceutical Co (SZSE:301281), the current Interest Coverage is 614.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Keyuan Pharmaceutical Co (SZSE:301281) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Keyuan Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥50.42 is trading 65.8% above its estimated GF Value™ of ¥30.41.
GuruFocus considers Shandong Keyuan Pharmaceutical Co to be Significantly Overvalued.
Key valuation signals for SZSE:301281:
Interest Coverage: 614.00 (420% above median its 10-year median of 118.08)
GF Value™: ¥30.41 vs. price of ¥50.42 (65.8% above fair value)
Industry Position: 4715.7% above the Drug Manufacturers median (#144 of 687)
No single metric tells the full story. See the SZSE:301281 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Keyuan Pharmaceutical Co Business Description
Shandong Keyuan Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of chemical raw materials and their preparations.
67GF Score
Get the complete analysis for SZSE:301281
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:301281 has been successfully added to your 
